IL-15 maintains T-cell survival via S-nitrosylation-mediated inhibition of caspase-3

Cell Death and Differentiation

Volumn 21, Issue 6, 2014, Pages 904-914

  Saligrama, P T ^a   Fortner, K A ^a   Secinaro, M A ^a   Collins, C C ^a   Russell, J Q ^a   Budd, R C ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

caspase 3; interleukin 15; metabolism; reactive species; S nitrosylation

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; INTERLEUKIN 15; INTERLEUKIN 2; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; EFFECTOR CELL; ENZYME INHIBITION; ENZYME REGULATION; GLYCOLYSIS; METABOLISM; MOUSE; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SENSITIZATION; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; GENETICS; LYMPHOCYTE ACTIVATION; MITOCHONDRION; SIGNAL TRANSDUCTION;

MURINAE;

ANIMALS; APOPTOSIS; CASPASE 3; CELL SURVIVAL; GLYCOLYSIS; INTERLEUKIN-15; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MITOCHONDRIA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84899907234     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.10     Document Type: Article

References (60)

1. Malek TR. The biology of interleukin-2. Annu Rev Immunol 2008; 26: 453-479.
2. Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 1996; 4: 329-336.
3. Oh S, Perera LP, Terabe M, Ni L, Waldmann TA, Berzofsky JA. IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis. Proc Natl Acad Sci USA 2008; 105: 5201-5206.
4. Waldmann T. The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases. Arthritis Res 2002; 4(Suppl 3): S161-S167.
5. Lenardo MJ. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 1991; 353: 858-861.
6. Brincks EL, Woodland DL. Novel roles for IL-15 in T cell survival. F1000 Biol Rep 2010; 2: 67.
7. Marks-Konczalik J, Dubois S, Losi JM, Sabzevari H, Yamada N, Feigenbaum L et al. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci USA 2000; 97: 11445-11450.
8. Kennedy NJ, Kataoka T, Tschopp J, Budd RC. Caspase activation is required for T cell proliferation. J Exp Med 1999; 190: 1891-1896.
9. Chun HJ, Zheng L, Ahmad M, Wang J, Speirs CK, Siegel RM et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002; 419: 395-399.
10. Salmena L, Lemmers B, Hakem A, Matysiak-Zablocki E, Murakami K, Au PY et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003; 17: 883-895.
11. Fuentes-Prior P, Salvesen GS. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J 2004; 384(Pt 2): 201-232.
12. Mannick JB. Regulation of apoptosis by protein S-nitrosylation. Amino Acids 2007; 32: 523-526.
13. Lane P, Hao G, Gross SS. S-nitrosylation is emerging as a specific and fundamental posttranslational protein modification: head-to-head comparison with O-phosphorylation. Sci STKE 2001; 2001: re1.
14. Mitchell DA, Morton SU, Fernhoff NB, Marletta MA. Thioredoxin is required for S-nitrosation of procaspase-3 and the inhibition of apoptosis in Jurkat cells. Proc Natl Acad Sci USA 2007; 104: 11609-11614.
15. Mannick JB, Schonhoff C, Papeta N, Ghafourifar P, Szibor M, Fang K et al. S-Nitrosylation of mitochondrial caspases. J Cell Biol 2001; 154: 1111-1116.
16. Kaur N, Naga OS, Norell H, Al-Khami AA, Scheffel MJ, Chakraborty NG et al. T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules. Cytokine 2011; 55: 307-317.
17. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol 2001; 3: 193-197.
18. Mitchell DA, Marletta MA. Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine. Nat Chem Biol 2005; 1: 154-158.
19. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314.
20. Cornish GH, Sinclair LV, Cantrell DA. Differential regulation of T-cell growth by IL-2 and IL-15. Blood 2006; 108: 600-608.
21. Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, Wang LS et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009; 460: 103-107.
22. van der Windt GJ, Everts B, Chang CH, Curtis JD, Freitas TC, Amiel E et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 2012; 36: 68-78.
23. Hubner A, Barrett T, Flavell RA, Davis RJ. Multisite phosphorylation regulates Bim stability and apoptotic activity. Mol Cell 2008; 30: 415-425.
24. Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis. Genes Dev 1999; 13: 239-252.
25. Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang ZW, Alnemri ES. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J Biol Chem 2000; 275: 36152-36157.
26. Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 2011; 43: 449-463.
27. Denault JB, Salvesen GS. Human caspase-7 activity and regulation by its N-terminal peptide. J Biol Chem 2003; 278: 34042-34050.
28. Wherry EJ, Becker TC, Boone D, Kaja MK, Ma A, Ahmed R. Homeostatic proliferation but not the generation of virus specific memory CD8 T cells is impaired in the absence of IL-15 or IL-15Ralpha. Adv Exp Med Biol 2002; 512: 165-175.
29. Mannick JB, Hausladen A, Liu LM, Hess DT, Zeng M, Miao QX et al. Fas-induced caspase denitrosylation. Science 1999; 284: 651-654.
30. Forrester MT, Foster MW, Benhar M, Stamler JS. Detection of protein S-nitrosylation with the biotin-switch technique. Free Radic Biol Med 2009; 46: 119-126.
31. Jaffrey SR, Snyder SH. The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 2001; 2001: pl1.
32. Martinez-Ruiz A, Lamas S. Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: convergences and divergences. Cardiovasc Res 2007; 75: 220-228.
33. Dickinson DA, Forman HJ. Glutathione in defense and signaling: lessons from a small thiol. Ann NY Acad Sci 2002; 973: 488-504.
34. Misra RS, Jelley-Gibbs DM, Russell JQ, Huston G, Swain SL, Budd RC. Effector CD4+ T cells generate intermediate caspase activity and cleavage of caspase-8 substrates. J Immunol 2005; 174: 3999-4009.
35. Beisner DR, Ch'en IL, Kolla RV, Hoffmann A, Hedrick SM. Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J Immunol 2005; 175: 3469-3473.
36. Kang TB, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A et al. Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol 2004; 173: 2976-2984.
37. Liadis N, Salmena L, Kwan E, Tajmir P, Schroer SA, Radziszewska A et al. Distinct in vivo roles of caspase-8 in beta-cells in physiological and diabetes models. Diabetes 2007; 56: 2302-2311.
38. Bidere N, Snow AL, Sakai K, Zheng L, Lenardo MJ. Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-kappaB activation. Curr Biol 2006; 16: 1666-1671.
39. Misra RS, Russell JQ, Koenig A, Hinshaw-Makepeace JA, Wen R, Wang D et al. Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation. J Biol Chem 2007; 282: 19365-19374.
40. Koenig A, Russell JQ, Rodgers WA, Budd RC. Spatial differences in active caspase-8 defines its role in T-cell activation versus cell death. Cell Death Differ 2008; 15: 1701-1711.
41. Weinlich R, Dillon CP, Green DR. Ripped to death. Trends Cell Biol 2011; 21: 630-637.
42. Green DR, Oberst A, Dillon CP, Weinlich R, Salvesen GS. RIPK-dependent necrosis and its regulation by caspases: a mystery in five acts. Mol Cell 2011; 44: 9-16.
43. Berard M, Brandt K, Bulfone-Paus S, Tough DF. IL-15 promotes the survival of naive and memory phenotype CD8+ T cells. J Immunol 2003; 170: 5018-5026.
44. Sandau MM, Kohlmeier JE, Woodland DL, Jameson SC. IL-15 regulates both quantitative and qualitative features of the memory CD8 T cell pool. J Immunol 2010; 184: 35-44.
45. Cantrell DA, Smith KA. Transient expression of interleukin 2 receptors. Consequences for T cell growth. J Exp Med 1983; 158: 1895-1911.
46. Thai PT, Collins CC, Fortner KA, Koenig A, Hayes SM, Budd RC. Increased caspase activity primes human Lyme arthritis synovial gammadelta T cells for proliferation and death. Hum Immunol 2011; 72: 1168-1175.
47. Aouad SM, Cohen LY, Sharif-Askari E, Haddad EK, Alam A, Sekaly RP. Caspase-3 is a component of Fas death-inducing signaling complex in lipid rafts and its activity is required for complete caspase-8 activation during Fas-mediated cell death. J Immunol 2004; 172: 2316-2323.
48. Rossig L, Fichtlscherer B, Breitschopf K, Haendeler J, Zeiher AM, Mulsch A et al. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem 1999; 274: 6823-6826.
49. Hernansanz-Agustin P, Izquierdo-Alvarez A, Garcia-Ortiz A, Ibiza S, Serrador JM, Martinez-Ruiz A. Nitrosothiols in the immune system: signaling and protection. Antioxid Redox Signal 2013; 18: 288-308.
50. Kruger NJ, von Schaewen A. The oxidative pentose phosphate pathway: structure and organisation. Curr Opin Plant Biol 2003; 6: 236-246.
51. Bobbala D, Chen XL, Leblanc C, Mayhue M, Stankova J, Tanaka T et al. Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse. Diabetologia 2012; 55: 3010-3020.
52. Kivisakk P, Matusevicius D, He B, Soderstrom M, Fredrikson S, Link H. IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS). Clin Exp Immunol 1998; 111: 193-197.
53. Kuczynski S, Winiarska H, Abramczyk M, Szczawinska K, Wierusz-Wysocka B, Dworacka M. IL-15 is elevated in serum patients with type 1 diabetes mellitus. Diabetes Res Clin Pract 2005; 69: 231-236.
54. Aringer M, Stummvoll GH, Steiner G, Koller M, Steiner CW, Hofler E et al. Serum interleukin-15 is elevated in systemic lupus erythematosus. Rheumatology (Oxford) 2001; 40: 876-881.
55. Liu Z, Geboes K, Colpaert S, D'Haens GR, Rutgeerts P, Ceuppens JL. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J Immunol 2000; 164: 3608-3615.
56. Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 2000; 119: 996-1006.
57. McInnes IB, al-Mughales J, Field M, Leung BP, Huang FP, Dixon R et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 1996; 2: 175-182.
58. Thurkow EW, van der Heijden IM, Breedveld FC, Smeets TJ, Daha MR, Kluin PM et al. Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. J Pathol 1997; 181: 444-450.
59. Baslund B, Tvede N, Danneskiold-Samsoe B, Larsson P, Panayi G, Petersen J et al. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study.[see comment]. Arthritis Rheum 2005; 52: 2686-2692.
60. Migita K, Yamasaki S, Kita M, Ida H, Shibatomi K, Kawakami A et al. Nitric oxide protects cultured rheumatoid synovial cells from Fas-induced apoptosis by inhibiting caspase-3. Immunology 2001; 103: 362-367.